Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Autoantibodies against nucleic acids and excessive type I interferon (IFN) are hallmarks of human systemic lupus erythematosus (SLE). We previously reported that SLE neutrophils exposed to TLR7 agonist autoantibodies release interferogenic DNA, which we now demonstrate to be of mitochondrial origin. We further show that healthy human neutrophils do not complete mitophagy upon induction of mitochondrial damage. Rather, they extrude mitochondrial components, including DNA (mtDNA), devoid of oxidized (Ox) residues. When mtDNA undergoes oxidation, it is directly routed to lysosomes for degradation. This rerouting requires dissociation from the transcription factor A mitochondria (TFAM), a dual high-mobility group (HMG) protein involved in maintenance and compaction of the mitochondrial genome into nucleoids. Exposure of SLE neutrophils, or healthy IFN-primed neutrophils, to antiribonucleotide protein autoantibodies blocks TFAM phosphorylation, a necessary step for nucleoid dissociation. Consequently, Ox nucleoids accumulate within mitochondria and are eventually extruded as potent interferogenic complexes. In support of the in vivo relevance of this phenomenon, mitochondrial retention of Ox nucleoids is a feature of SLE blood neutrophils, and autoantibodies against Ox mtDNA are present in a fraction of patients. This pathway represents a novel therapeutic target in human SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Different cellular lineages (10–18) may extrude their mitochondria upon activation.”
From Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA (2019) · cites this paper as [12]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Extracellular mitochondria have been identified in damaged tissues (8, 18–20); diverse inflammatory conditions (11, 12, 14, 21–24); and in the blood of critical care patients (22).”
From Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA (2019) · cites this paper as [12]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Various cellular lineages are capable of extruding their mitochondria. Activated mast cells10, T-cells11, eosinophils12, hepatocytes13, neutrophils14–16 and platelets17,18, in addition to damaged organs or tissues7,13,19,20, release extracellular mitochondria.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Extracellular mitochondria have been described in various clinical conditions, including trauma25,26, burn injury27, cancer28, rheumatoid arthritis17,29, systemic lupus erythematosus (SLE)15,16 and transfusion adverse reactions17,18,30,31.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several reports demonstrate that a considerable fraction of the nucleic acids contained in NETs is of mitochondrial, rather than nuclear, origin [724–728].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [727]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 2×
“mtDNA activates neutrophils through TLR9 engagement (Zhang et al., 2010) and, upon cytoplasmic leakage, leads to cell autonomous NLRP3 and TLR9 activation (Nakahira et al.”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · cited 2×
“, 2010) and, upon cytoplasmic leakage, leads to cell autonomous NLRP3 and TLR9 activation (Nakahira et al., 2011; Oka et al., 2012).”
BackgroundOxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282 · cited 1×
“3 A, bottom). mtDNA is highly susceptible to oxidation (Yakes and Van Houten, 1997), a proinflammatory modification (Shimada et al., 2012).”
BackgroundInterferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958 · cited 1×
“Expression of IFN- and neutrophil-related transcripts correlates with disease activity, and common allelic gene variants within these pathways confer disease susceptibility (Bennett et al., 2003; Moser et al., 2009; Bentham et al., 2015).”
BackgroundSelf-citationPlasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 2×
“Addition of the cationic peptide LL-37 to facilitate their uptake (Lande et al., 2007) resulted in a 10fold increase in IFN-α levels in the presence of Ox mtDNA (Fig.”
BackgroundThe pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900 · cited 1×
“This process requires autophagy activation, sequestration of damaged mitochondria into autophagosomes, and fusion of autophagosomes with lysosomes (Ashrafi and Schwarz, 2013).”
BackgroundYakes, F. M., & Van Houten, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.514 · Cited by 1,854
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383 · cited 11×
“5 DIS CUS SION SLE neutrophils extrude interferogenic DNA when activated with anti-Sm/RNP antibodies in an FcγR, TLR7, and ROS-dependent manner (Garcia-Romo et al., 2011).”
BackgroundMethodInfluentialSelf-citation
Cited by
Items 101–200 of 502
Qiu, C. C., Caricchio, R., & Gallucci, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02608 · Cited by 116
The crucial regulatory role of type I interferon in inflammatory diseases
Ji, L., Li, T., Chen, H., Yang, Y., Lu, E., Liu, J., Qiao, W., & Chen, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01188-z · Cited by 119
“This conclusion has been confirmed by demonstrating that oxidized mtDNA drove IFN-Is secretion through the TLR9 pathway in humans with SLE [150, 151].”
BackgroundMitochondrial DNA damage triggers spread of Parkinson’s disease-like pathology
Tresse, E., Marturia-Navarro, J., Sew, W. Q. G., Cisquella-Serra, M., Jaberi, E., Riera-Ponsati, L., Fauerby, N., Hu, E., Kretz, O., Aznar, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02251-4 · Cited by 99
“Of note, we did not observe a role for cGAS-STING pathway, one of the earlier suggested main players [62 – 64], in our reported neuronal pathologies.”
BackgroundFang, C., Mo, F., Liu, L., Du, J., Luo, M., Men, K., Na, F., Wang, W., Yang, H., & Wei, X. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0456-1 · Cited by 112
“In addition, oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in lupus.(26,27) However, the role of mtDNA or oxidized mtDNA in the activation of antitumor immunity remains unexplored.”
BackgroundSystemic lupus erythematosus and systemic sclerosis: All roads lead to platelets
Scherlinger, M., Guillotin, V., Truchetet, M., Contin‐Bordes, C., Sisirak, V., Duffau, P., Lazaro, E., Richez, C., & Blanco, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.012 · Cited by 107
Innate immunity and tolerance toward mitochondria
Rongvaux, A. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.10.007 · Cited by 98
Vascular damage in systemic lupus erythematosus
Ambler, W. G., & Kaplan, M. J. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00797-8 · Cited by 116
“SLE NETs also supply enhanced levels of oxidized genomic and mitochondrial DNA, which further augment the IFN-I response through stimulation of the cytosolic cyclic GMP-AMP synthase (cGAS)-STING pathway 105,116,117 .”
Hu, H., Guo, L., Overholser, J. P., & Wang, X. (2022) · Cells · doi:10.3390/cells11193174 · Cited by 103
Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics
Banchereau, R., Cepika, A., Banchereau, J., & Pascual, V. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052225 · Cited by 121
Self-citationLupus and proliferative nephritis are PAD4 independent in murine models
Gordon, R. A., Herter, J. M., Rosetti, F., Campbell, A. M., Nishi, H., Kashgarian, M. J., Bastacky, S., Marinov, A. D., Nickerson, K. M., Mayadas, T. N., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92926 · Cited by 103
“Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by loss of tolerance to nuclear antigens, resulting in the formation of autoantibodies against DNA, RNA, and ribonuclear proteins, rampant immune activation, and tissue destruction (1).”
BackgroundInfluentialMitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis
Clayton, S. A., MacDonald, L., Kurowska‐Stolarska, M., & Clark, A. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673916 · Cited by 103
“NETosis-independent release of oxmtDNA from neutrophils has also been demonstrated, which potently stimulates type I interferon production by plasmacytoid DCs, and this study found that some individuals with SLE develop antibodies against ox-mtDNA (59).”
BackgroundSelf-citationOxidized mitochondrial DNA: a protective signal gone awry
Xian, H., & Karin, M. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.01.006 · Cited by 99
Mitochondrial DNA Damage: Prevalence, Biological Consequence, and Emerging Pathways
Zhao, L., & Sumberaz, P. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00083 · Cited by 97
Metabolism and Innate Immunity Meet at the Mitochondria
Bahat, A., MacVicar, T., & Langer, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720490 · Cited by 90
The role of neutrophils in rheumatic disease-associated vascular inflammation
Wang, L., Luqmani, R. A., & Udalova, I. A. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00738-4 · Cited by 98
The role of mitophagy in innate immune responses triggered by mitochondrial stress
Song, Y., Zhou, Y., & Zhou, X. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00659-x · Cited by 97
“In addition to eliciting pro-inflammatory responses, extracellular oxidized mtDNA has been shown to induce the TLR9- and IRF7-dependent production of IFN-α to augment type I IFN responses in pDCs [70].”
BackgroundMarcoux, G., Magron, A., Sut, C., Laroche, A., Laradi, S., Hamzeh‐Cognasse, H., Allaeys, I., Cabon, O., Julien, A., Garraud, O., et al. (2019) · Transfusion · doi:10.1111/trf.15300 · Cited by 87
“Moreover, mtDNA has been assessed in a multitude of inflammatory conditions, including trauma,(37,44) burn injury,(43) hepatitis, cancer,(66) rheumatoid arthritis,(38,39) and systemic lupus erythematosus.(40,41) Considering that the induction of platelet EVs is frequently observed in inflammation, it would be interest…”
BackgroundMetabolic abnormalities and oxidative stress in lupus
Lightfoot, Y. L., Blanco, L. P., & Kaplan, M. J. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000413 · Cited by 90
DNA Sensing across the Tree of Life
Gallucci, S., & Maffei, M. E. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.012 · Cited by 90
“mtDNA is considered a major source of self-DNA in lupus, because (i) the injection of mtDNA can stimulate DNA-specific autoimmunity [100,101]; (ii) autoimmune complexes can stimulate the NETTing process in SLE patients, therefore increasing the exposure of the immune system to mtDNA [102]; and (iii) antagonists of TLR…”
BackgroundOpportunities and limitations of B cell depletion approaches in SLE
Stockfelt, M., Teng, Y. K. O., & Vital, E. M. J. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01210-9 · Cited by 99
“Ribonucleoprotein-containing immune complexes and TLR activation increase NET formation and the extrusion of mtDNA 152–154 .”
Roles of secreted phospholipase A2 group IIA in inflammation and host defense
Doré, É., & Boilard, É. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.08.017 · Cited by 96
Toll-like receptors in lupus nephritis
Devarapu, S. K., & Anders, H. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0436-2 · Cited by 92
Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Wirestam, L., Arve-Butler, S., Linge, P., & Bengtsson, A. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02734 · Cited by 92
Huang, N., Winans, T., Wyman, B., Oaks, Z., Faludi, T., Choudhary, G., Lai, Z., Lewis, J., Beckford, M., Duarte, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46441-2 · Cited by 92
“The accumula-tionofoxidativestress-generatingmitochondriainlupusTcells 13,46 has been widely con fi rmed 88,89 and recently extended to myeloid cells, suchasneutrophils 90,91 and erythroid cells of patients with SLE 92 .”
BackgroundJuvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care
Papadopoulou, C., Chew, C., Wilkinson, M. G. L., McCann, L. J., & Wedderburn, L. R. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00967-9 · Cited by 82
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Koenig, A., & Buskiewicz, I. A. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0073 · Cited by 81
“…have been shown to be high (24, 106). oxo-mtDNA oxo-mtDNA released from neutrophils in SLE patients was reported to interact with TLR9 on plasma-cytoid dendritic cells (pDCs), drive type I IFN production, and have increased immunostimulatory potency compared with nonoxidized mtDNA (24, 139).”
Muscle-derived small extracellular vesicles induce liver fibrosis during overtraining
Liu, Y., Zhou, R., Guo, Y., Hu, B., Xie, L., An, Y., Wen, J., Liu, Z., Zhou, M., Kuang, W., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2024.12.005 · Cited by 78
Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy
Hong, S., Banchereau, R., Maslow, B.-S. L., Guerra, M. M., Cardenas, J., Baisch, J. M., Branch, D. W., Porter, T. F., Sawitzke, A. D., Laskin, C. A., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190185 · Cited by 78
“Neutrophils are a source of interferogenic nucleic acids (Caielli et al., 2016; Lood et al., 2016) and IFN α has been shown in vitro to prevent stabilization of endothelial cells and thus potentially contribute to PE (Andrade et al., 2015).”
Self-citationScozzi, D., Ibrahim, M., Liao, F., Lin, X., Hsiao, H.-M., Hachem, R. R., Tague, L. K., Rícci, A., Kulkarni, H. S., Huang, H. J., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15232 · Cited by 78
An update on autoantibodies in systemic lupus erythematosus
Gómez-Bañuelos, E., Fava, A., & Andrade, F. (2022) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000922 · Cited by 90
Majewski, P., Majchrzak-Gorecka, M., Grygier, B., Skrzeczyńska-Moncznik, J., Osiecka, O., & Cichy, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00261 · Cited by 81
“This modification is required for the potent interferogenic potential of mitochondrial DNA (95).”
BackgroundBecker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40900-3 · Cited by 75
Mitochondrial control of innate immune responses
Chen, S., Liao, Z., & Xu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166214 · Cited by 101
How Neutrophils Shape the Immune Response: Reassessing Their Multifaceted Role in Health and Disease
Shafqat, A., Khan, J. A., Alkachem, A. Y., Sabur, H., AlKattan, K. M., Yaqinuddin, A., & Sing, G. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417583 · Cited by 93
“In contrast, LDGs stimulated by ribonucleoprotein (RNP)-ICs in SLE upregulate mitochondrial ROS production and the oxidation of mitochondrial DNA that is then extruded in oxidized mitochondrial DNA-containing NETs in an NADPH oxidase-independent manner [286,287].”
BackgroundMitochondrial DNA signals driving immune responses: Why, How, Where?
Giordano, L., Ware, S. A., Lagranha, C. J., & Kaufman, B. A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02042-0 · Cited by 86
“Extracellular mtDNA plays a key role in the formation of the extracellular traps (ETs), a response of the immune system mainly induced by bacterial, viral, and parasite infection [136, 137], but also by traumas [138], cancer [139, 140], and autoimmunity [141–143].”
Catalina, M. D., Bachali, P., Yeo, A. E. T., Geraci, N., Petri, M., Grammer, A. C., & Lipsky, P. E. (2020) · JCI Insight · doi:10.1172/jci.insight.140380 · Cited by 74
“21 patients with anti-RNP autoantibodies may be the extrusion of interferonogenic, oxidized mitochondrial DNA by neutrophils in response to anti-Sm/RNP autoantibodies(52, 53).”
BackgroundLyu, Y., Wang, T., Huang, S., & Zhang, Z. (2023) · Journal of Innate Immunity · doi:10.1159/000533602 · Cited by 84
“Oxidative mtDNA released by neutrophils also drives IFN production via the TLR9 pathway in human systemic lupus erythematosus (SLE) [72].”
BackgroundGanguly, D. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.001 · Cited by 72
Chowdhury, C. S., Kinsella, R. L., McNehlan, M. E., Naik, S. K., Lane, D. S., Talukdar, P., Smirnov, A., Dubey, N., Rankin, A. N., McKee, S. R., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.11.008 · Cited by 78
Mobarrez, F., Fuzzi, E., Gunnarsson, I., Larsson, A., Eketjäll, S., Pisetsky, D. S., & Svenungsson, E. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.05.003 · Cited by 68
NETosis – Does It Really Represent Nature’s “Suicide Bomber”?
Yousefi, S., & Simon, H.-U. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00328 · Cited by 68
Georgakis, S., Gkirtzimanaki, K., Papadaki, G., Gakiopoulou, H., Drakos, E., Eloranta, M., Makridakis, M., Kontostathi, G., Zoidakis, J., Baira, E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147671 · Cited by 73
“147671 under oxidative stress driven by mitochondrial ROS (16, 60), it is of interest to discern how NET-associated IL-33 may retain its bioactivity.”
BackgroundInfluentialMitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury
Liao, S., Luo, J., Kadier, T., Ding, K., Chen, R., & Meng, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.854994 · Cited by 77
“Oxidative mtDNA has been shown to trigger the TLR9 pathway, and oxidative mtDNA released by neutrophils induces plasmacytoid DCs (pDCs) to produce type I interferon (Caielli et al., 2016).”
BackgroundMitochondrial targeting as a novel therapy for stroke
Borlongan, C., Russo, E., Nguyen, H., Lippert, T., Tuazon, J. P., & Napoli, E. (2018) · Brain Circulation · doi:10.4103/bc.bc_14_18 · Cited by 70
“[175,176] Extrusion of whole mitochondria or their components has been reported as an alternative mechanism of mitochondria transfer.[177,178]”
BackgroundAmodio, G., Cichy, J., Conde, P., Matteoli, G., Moreau, A., Ochando, J., Oral, B. H., Pekarová, M., Ryan, E. J., Roth, J., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2264-3 · Cited by 70
“Upon tissue injury or pathogen entry, PMNs are recruited at the site of inflammation and, by secreting pro-inflammatory mediators, lead to the activation of plasmacytoid DC (pDCs), which consequently release IFN-α.”
BackgroundInfluentialSources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus
Mustelin, T., Lood, C., & Giltiay, N. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01028 · Cited by 78
“Mitochondrial DNA Another source of nucleic acids are the mitochondria (95, 96), which serve many functions besides oxidative phosphorylation and production of ATP, such as metabolism, inflammation and cell death.”
BackgroundEmerging role of mitochondria in airborne particulate matter-induced immunotoxicity
Sharma, J., Parsai, K., Raghuwanshi, P., Ali, S. A., Tiwari, V., Bhargava, A., & Mishra, P. K. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.116242 · Cited by 70
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response
Londe, A. C., Fernandez‐Ruiz, R., Júlio, P. R., Appenzeller, S., & Niewold, T. B. (2023) · The Journal of Rheumatology · doi:10.3899/jrheum.2022-0827 · Cited by 76
“This process is mainly mediated by the constitutively expressed transcription factor interferon regulatory factor (IRF) 7, 9-11 although other transcription factors such as IRF5 and IRF3 also play an important role in mediating cytokine production by pDCs. 12 DNA and RNA molecules can also bind to…”
BackgroundNETosis: an emerging therapeutic target in renal diseases
Juha, M., Molnár, A., Jakus, Z., & Ledó, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1253667 · Cited by 67
“They activate neutrophils via FcgR pathways and induce mitochondria-dependent NETosis (79, 80).”
BackgroundCaneparo, V., Landolfo, S., Gariglio, M., & Andrea, M. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01180 · Cited by 76
“Interestingly, NETs from low-density granulocyte of SLE patients are highly enriched in mtDNA compared with NETs from healthy controls neutrophils (95), whereas abnormal extrusion of oxidized mtDNA from SLE patient neutrophils may triggers a pathogenic interferogenic response (96).”
BackgroundNeutrophils in lupus nephritis
Nishi, H., & Mayadas, T. N. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000577 · Cited by 68
Targeted mitochondrial delivery: A therapeutic new era for disease treatment
Huang, T., Zhang, T., & Gao, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.025 · Cited by 66
Alarmins of the S100-Family in Juvenile Autoimmune and Auto-Inflammatory Diseases
Holzinger, D., Tenbrock, K., & Roth, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00182 · Cited by 64
“In addition, incubation of healthy tissue or cells with alarmins can induce a sterile inflammation (13), while specific deletion of alarmins in genetically targeted mice results in amelioration of experimental disease like arthritis or sepsis.”
BackgroundOxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model
Tumurkhuu, G., Chen, S., Montano, E. N., Laguna, D. E., Santos, G. D. L., Yu, J. M., Lane, M. E., Yamashita, M., Markman, J. L., Blanco, L. P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.554725 · Cited by 62
Endoplasmic reticulum stress sensor IRE1α propels neutrophil hyperactivity in lupus
Sule, G. J., Abuaita, B. H., Steffes, P. A., Fernandes, A. T., Estes, S. K., Dobry, C. J., Pandian, D., Gudjonsson, J. E., Kahlenberg, J. M., O’Riordan, M. X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137866 · Cited by 67
“Indeed, others have shown that RNP–anti-RNP–mediated mitoROS drive the oxidation of mitoDNA (7), which is probably a key player in downstream activation of immune responses (18).”
BackgroundImmunometabolism in systemic lupus erythematosus
Patiño‐Martínez, E., & Kaplan, M. J. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01267-0 · Cited by 79
“Impaired mitophagy has also been reported in SLE neutrophils, with retention of oxidized nucleotides in the mitochondria 62 .”
Mitochondrial functions and rare diseases
Dard, L., Blanchard, W., Hubert, C., Lacombe, D., & Rossignol, R. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100842 · Cited by 68
Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P. R., & Boilard, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01026 · Cited by 59
“With the accumulating evidence supporting the liberation of mitochondrial components into the extracellular milieu in SLE (11, 12), it is crucial to identify the various mitochondrial antigens.”
BackgroundYuzefovych, L. V., Pastukh, V. M., Ruchko, M. V., Simmons, J. D., Richards, W. O., & Rachek, L. I. (2019) · PLOS ONE · doi:10.1371/journal.pone.0222278 · Cited by 59
Stojkov, D., Gigon, L., Peng, S., Łukowski, R., Ruth, P., Karaulov, A. V., Rizvanov, A. A., Barlev, N. A., Yousefi, S., & Simon, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.826515 · Cited by 69
Duvvuri, B., Baddour, A. A., Deane, K. D., Feser, M. L., Nelson, J. L., Demoruelle, M. K., & Lood, C. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102630 · Cited by 58
Ryu, C., Walia, A., Ortiz, V., Perry, C., Woo, S., Reeves, B. C., Sun, H., Winkler, J., Kanyo, J. E., Wang, W., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41418 · Cited by 62
“These findings have the potential to be relevant to scleroderma-related lung disease, but also in other TLR-9 or cGAS/STING-related conditions, including but not limited to acute respiratory distress syndrome (32), tuberculosis (33), and systemic lupus erythematosus (34).”
BackgroundVRK2 is involved in the innate antiviral response by promoting mitostress-induced mtDNA release
He, W.-R., Cao, L.-B., Yang, Y.-L., Hua, D., Hu, M., & Shu, H. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00673-0 · Cited by 65
Picca, A., Guerra, F., Calvani, R., Coelho‐Júnior, H. J., Landi, F., Bernabei, R., Romanò, R., Bucci, C., & Marzetti, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601740 · Cited by 60
“In systemic lupus erythematosus, mtDNA binding to the histone-like protein mitochondrial transcription factor A (TFAM) has shown to assist in rerouting oxidized mtDNA of neutrophils to lysosomes for degradation (89).”
BackgroundMitochondrial-derived vesicles: Gatekeepers of mitochondrial response to oxidative stress
Peng, T., Xie, Y., Sheng, H., Wang, C., Lian, Y., & Xie, N. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.233 · Cited by 69
Diversity and environmental adaptation of phagocytic cell metabolism
Davies, L. C., Rice, C. M., McVicar, D. W., & Weiss, J. M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0518-195r · Cited by 59
“This induced mitochondrial ROS and partially restored the ability of NOX-deficient neutrophils to combat staphylococcus aureus, demonstrating a potential compensatory mechanism of mitochondria to support NOX activity.93 Neutrophil extracellular traps (NETs) are of recent interest to the field of neutrophil metabolism.”
InfluentialMetabolism as a key regulator in the pathogenesis of systemic lupus erythematosus
Takeshima, Y., Iwasaki, Y., Fujio, K., & Yamamoto, K. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.04.006 · Cited by 66
Smith, N., Rodero, M. P., Bekaddour, N., Bondet, V., Ruiz‐Blanco, Y. B., Harms, M., Mayer, B., Bader‐Meunier, B., Quartier, P., Bodemer, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav9019 · Cited by 59
Therapeutic applications of mitochondrial transplantation
Ülger, Ö., & Kubat, G. B. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.002 · Cited by 59
NET formation is independent of gasdermin D and pyroptotic cell death
Stojkov, D., Claus, M., Kozlowski, E., Oberson, K., Schären, O. P., Benarafa, C., Yousefi, S., & Simon, H. (2023) · Science Signaling · doi:10.1126/scisignal.abm0517 · Cited by 63
Mitochondrial DNA as inflammatory DAMP: a warning of an aging immune system?
Zanini, G., Selleri, V., Doménech, S. L., Malerba, M., Nasi, M., Mattioli, A. V., & Pinti, M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221010 · Cited by 62
Mitochondrial Dysfunction in Stroke: Implications of Stem Cell Therapy
Sarmah, D., Kaur, H., Saraf, J., Vats, K., Pravalika, K., Wanve, M., Kalia, K., Borah, A., Kumar, A., Wang, X., et al. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0642-y · Cited by 59
Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus
Zhao, L., Hu, X., Xiao, F., Zhang, X., Zhao, L., & Wang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.929520 · Cited by 64
“However, exposure to the IFNa/RNP immune complex disrupts mitochondrial degradation, leading to the accumulation of abundant Ox-mtDNA within mitochondria and eventually out of mitochondria, which would be a potent pDC stimulator (49).”
BackgroundDermatologic Manifestations of Mitochondrial Dysfunction: A Review of the Literature
Natarelli, N., Gahoonia, N., Aflatooni, S., Bhatia, S., & Sivamani, R. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063303 · Cited by 59
“A 2016 study analyzed the role of oxidized mitochondrial nucleoids in SLE [53].”
BackgroundType I IFN drives unconventional IL-1β secretion in lupus monocytes
Caielli, S., Balasubramanian, P., Rodríguez-Alcázar, J. F., Balaji, U., Robinson, L. A., Wan, Z., Baisch, J. M., Smitherman, C., Walters, L., Sparagana, P. R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.004 · Cited by 59
Self-citationMitochondrial DNA in cell death and inflammation
Heilig, R., Lee, J., & Tait, S. W. G. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221525 · Cited by 63
Feng, Z., Jin, M., Liang, J., Kang, J., Yang, H., Guo, S., & Sun, X. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.03.032 · Cited by 55
Mitochondria break free: Mitochondria-derived vesicles in aging and associated conditions
Ferrucci, L., Guerra, F., Bucci, C., Marzetti, E., & Picca, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102549 · Cited by 63
“…neutrophils showed that oxidized mtDNA was first accumulated within mitochondria and extruded thereafter in a complex with mitochondrial proteins (Caielli et al., 2016). mtDNA extrusion was promoted under neutrophil stimulation with the oxidative phosphorylation inhibitor carbonyl cyanide…”
BackgroundInfluentialKlein, B., Reynolds, M. B., Xu, B., Gharaee‐Kermani, M., Gao, Y., Berthier, C. C., Henning, S., Tsoi, L. C., Loftus, S., McNeely, K. E., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ado1710 · Cited by 62
Expanding the B Cell-Centric View of Systemic Lupus Erythematosus
Morawski, P. A., & Bolland, S. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.02.001 · Cited by 57
“Yipp BG, Kubes P. NETosis: how vital is it?”
BackgroundInfluentialResearch and therapeutics—traditional and emerging therapies in systemic lupus erythematosus
Davis, L. S., & Reimold, A. M. (2017) · Rheumatology · doi:10.1093/rheumatology/kew417 · Cited by 55
Metabolic determinants of lupus pathogenesis
Teng, X., Brown, J., Choi, S., Li, W., & Morel, L. M. (2020) · Immunological Reviews · doi:10.1111/imr.12847 · Cited by 55
Melbouci, D., Ahmad, A. H., & Decker, P. (2023) · RMD Open · doi:10.1136/rmdopen-2023-003104 · Cited by 59
Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects
Soni, C., & Reizis, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01601 · Cited by 58
“However, in several SLE patients, due to the blocking effect of anti-RNP Abs or IFNs on TFAM, neutrophil-mtDNA is unable to dissociate from nucleoids, hence ox-mtDNA is retained within the neutrophils and expelled with NETs, which induces the production of type-I IFNs through pDCs (78).”
BackgroundThe Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus
Robinson, G., Wilkinson, M. G. L., & Wincup, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.806560 · Cited by 64
Short single-stranded DNA degradation products augment the activation of Toll-like receptor 9
Pohar, J., Lainšček, D., Ivičak‐Kocjan, K., Cajnko, M. M., Jerala, R., & Benčina, M. (2017) · Nature Communications · doi:10.1038/ncomms15363 · Cited by 55
“Another sources of cfDNA are injuries and mitochondrial DNA, which is released during systemic inflammatory response syndrome 16,17 .”
Santa, P., Garreau, A., Serpas, L., Ferrière, A., Blanco, P., Soni, C., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629922 · Cited by 71
“Furthermore, neutrophils undergo a specific cell death process called NETosis, which results in the release of DNA in the form of neutrophil extracellular traps (NETs) (48).”
BackgroundInfluentialDiverse Roles of NETosis in the Pathogenesis of Lupus
Wang, M., Ishikawa, T., Lai, Y., Nallapothula, D., & Singh, R. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.895216 · Cited by 64
“SLE neutrophils exposed to RNP IC induce the release of oxidized mitochondrial DNA, and NET enriched in oxidized mitochondrial DNA drive IFN-a production, thus can contribute to lupus disease (45, 51).”
BackgroundUpdate on the cellular and molecular aspects of lupus nephritis
Frangou, E. A., Georgakis, S., & Bertsias, G. K. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108445 · Cited by 51
Wilkinson, M. G. L., MOULDING, D. A., McDonnell, T. C. R., Orford, M., Wincup, C., Ting, J. Y. J., Otto, G., Restuadi, R., Kelberman, D., Papadopoulou, C., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223469 · Cited by 56
Zhang, J., Ji, H., Liu, M., Zheng, M., Wen, Z., & Shen, H. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300758 · Cited by 54
Advances in the treatment of systemic lupus erythematosus
Scherlinger, M., Kolios, A. G. A., Kyttaris, V. C., & Tsokos, G. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01242-0 · Cited by 62
“For example, monocytes may phagocytose red cells and produce IL-1 to activate the inflammasome and infiltrate tissues 18 , as well neutrophils, which undergo NETosis to release autoantigens and stimulate the immune system 19 .”
Lai, J., Hung, L., Huang, C., Wu, D., Wu, C., & Ho, L. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02470-6 · Cited by 52
Mitochondrial DNA and Exercise: Implications for Health and Injuries in Sports
Zanini, G., De Gaetano, A., Selleri, V., Savino, G., Cossarizza, A., Pinti, M., Mattioli, A. V., & Nasi, M. (2021) · Cells · doi:10.3390/cells10102575 · Cited by 46
Role of mitochondrial dysfunction on rheumatic diseases
Vaamonde‐García, C., & López-Armada, M. J. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.008 · Cited by 45
Inflammasome Fuels Dengue Severity
Shrivastava, G., Leon, P. C. V., & Calvo, E. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00489 · Cited by 55
“Mitochondria plays a crucial role in TLR9 mediated pathways as DAMPs released from mitochondria during tissue injury, stress conditions, and cytokine production due to trauma, trigger inflammatory responses through activation of the TLR9 signaling pathway (Zhang et al., 2010; Caielli et al., 2016; Lood et al., 2016).”
BackgroundInnate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections
Chi, X., Huang, M., Tu, H., Zhang, B., Lin, X., Xu, H., Dong, C., & Hu, X. (2023) · Science China Life Sciences · doi:10.1007/s11427-021-2187-3 · Cited by 50
“contents, including neutrophilic mitochondrial DNA which makes the major contribution to type I IFN production in SLE pDCs (Caielli et al., 2016; Lood et al., 2016).”
BackgroundNew Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus
Scherlinger, M., Sisirak, V., Richez, C., Lazaro, E., Duffau, P., & Blanco, P. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0678-0 · Cited by 51
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus
Chen, P.-M., & Tsokos, G. C. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01063-9 · Cited by 53
Metadata
- Authors
- Caielli, S., Athale, S., Domic, B., Murat, E., Chandra, M., Banchereau, R., Baisch, J., Phelps, K., Clayton, S., Gong, M., Wright, T., Punaro, M., Palucka, K., Guiducci, C., Banchereau, J., & Pascual, V.
- Affiliations
- Baylor Institute for Immunology Research, Dallas, TX 75204 1
- The University of Texas Southwestern Medical Center (US)
- Dynavax Technologies (United States) (US)
- Texas Scottish Rite Hospital for Children (US)
- The Jackson Laboratory for Genomic Medicine (US)
- Corresponding author
- Pascual, Virginia
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2016-04-18
- Volume
- 213
- Issue
- 5
- Pages
- 697-713
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4854735
- OpenAlex
- W2338241371
- Cited by
- 501
- References
- 52
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 64 · 2023: 64 · 2022: 55 · 2021: 44 · 2020: 42 · 2019: 45 · 2018: 49 · 2017: 33 · 2016: 17
- FWCI
- 51.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- National Institutes of Health (P50 AR054083-01, U19 AI082715)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- systemic lupus erythematosus, type I interferon, neutrophils, mitochondrial DNA, mitochondrial nucleoids, mitophagy, autoantibodies, lysosomal degradation, autoinflammation, therapeutic target
- MeSH terms
- Adolescent, Autoantibodies, Child, Child, Preschool, DNA-Binding Proteins, DNA, Mitochondrial, Female, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Male, Mitochondria, Neutrophils, Oxidation-Reduction, Transcription Factors, Mitochondrial Proteins, Toll-Like Receptor 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.